SEC Filing Summary for Philip Ron M - Insider Transaction

This filing details a transaction by Philip Ron M, a director at Avalo Therapeutics, Inc. On June 23, 2026, Philip Ron M was granted 40,200 stock options with a right to buy common stock at a price of $17.83 per share. These options vest in three equal annual installments, contingent upon continued service. The options have an expiration date of June 23, 2036. This transaction is reported on Form 4.